Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey

Meng Su(Chinese Academy of Medical Sciences & Peking Union Medical College), Lixin Jiang(Fudan University), George A. Mensah(Nurses' Training College, Ho), Yetong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Anwen Zhang(International Labour Organization), Jiapeng Lu(Tongren Hospital), Khurram Nasir(Houston Methodist), Frederick A. Masoudi(Bristol-Myers Squibb (United States)), Yuan Lu(Flatiron Health (United States)), Sebastian Salas-Vega(London School of Economics and Political Science), Harlan M. Krumholz(Yale New Haven Hospital), Xi Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Chaoqun Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Qiuli Zhang(ShenZhen People’s Hospital), Xueke Bai(Chinese Academy of Medical Sciences & Peking Union Medical College), Elías Mossialos(Imperial College London)
The Lancet
November 5, 2017
10.1016/s0140-6736(17)32476-5
Cited by 158

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.1k
Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.4k
Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association
|Circulation|2018|7.2k
Markers of Inflammation and Cardiovascular Disease
|Circulation|2003|6.3k
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k